TUDCA or NAC? Most users pick one at random, or take both without understanding what each does. It is the most common question we see in blood work reviews related to oral AAS, and the answer depends entirely on which liver markers are elevated. The two supplements are complementary, not interchangeable. One targets bile duct stress; the other targets oxidative damage. Choosing the right one requires understanding the difference between a cholestatic pattern and a hepatocellular injury pattern on your blood work.
TUDCA: The Bile Acid Protector
Tauroursodeoxycholic Acid (TUDCA) is a hydrophilic bile acid that protects liver cells from the toxic effects of hydrophobic bile acids. It works through three mechanisms: reducing endoplasmic reticulum (ER) stress, stabilizing mitochondrial membranes, and protecting cholangiocytes — the cells lining bile ducts. These mechanisms make TUDCA the preferred option when your blood work shows a cholestatic pattern: elevated GGT, elevated bilirubin (particularly direct or conjugated bilirubin), and possibly elevated ALP (alkaline phosphatase).
Cholestasis means bile flow is impaired and bile acids are accumulating in the liver. Oral AAS, particularly 17-alpha-alkylated compounds, are known to induce cholestasis by impairing bile acid transport at the canalicular membrane of hepatocytes. TUDCA directly counteracts this mechanism by displacing toxic hydrophobic bile acids and reducing the ER stress response.
The typical dose is 500-1,000 mg per day, taken with food. TUDCA is well-absorbed orally and reaches therapeutic concentrations in the liver within hours. Most clinical studies use 500-1,500 mg/day for cholestatic liver disease. For AAS users, 500 mg is a reasonable starting dose, with an increase to 1,000 mg if GGT remains elevated after 2-3 weeks. Side effects are minimal — occasional gastrointestinal discomfort at higher doses.
NAC: The Glutathione Recycler
N-Acetylcysteine (NAC) is a precursor to glutathione, the body's master antioxidant. By replenishing glutathione levels, NAC enhances the liver's ability to neutralize reactive oxygen species and detoxify harmful compounds. NAC is used clinically as an antidote for acetaminophen overdose, where it prevents potentially fatal liver necrosis by restoring glutathione reserves faster than the toxin can deplete them.
NAC is the preferred option when your blood work shows a hepatocellular injury pattern — elevated ALT and AST with normal GGT and normal bilirubin. This pattern indicates that liver cells are under oxidative stress but bile flow is intact. It is the most common liver enzyme pattern seen in AAS users, especially those using oral compounds. In this scenario, ALT and AST elevation reflects increased hepatic workload and oxidative stress rather than cholestatic injury.
The typical dose is 600-1,200 mg per day. NAC has relatively low oral bioavailability (approximately 10%), but this is sufficient for therapeutic effect. Higher doses (up to 2,000 mg/day) are used in clinical settings but may cause gastrointestinal side effects including nausea and loose stools. NAC should be taken on an empty stomach for optimal absorption.
Mechanism Comparison: TUDCA vs. NAC
The fundamental difference is that TUDCA is cytoprotective — it stabilizes cell membranes and reduces ER stress — while NAC is antioxidant — it scavenges reactive oxygen species and supports the liver's natural detoxification systems. One is a structural protectant, the other is a chemical defense booster. They do not compete; they complement.
TUDCA vs NAC: Head to Head
| Marker | TUDCA | NAC |
|---|---|---|
| Primary Mechanism | Bile acid, ER stress reducer, membrane stabilizer | Glutathione precursor, antioxidant, ROS scavenger |
| Best For | Cholestasis (elevated GGT, bilirubin) | Hepatocellular injury (elevated ALT/AST) |
| Typical Dose | 500-1,000 mg/day with food | 600-1,200 mg/day on empty stomach |
| Evidence Grade | Strong for cholestatic DILI | Strong for oxidative hepatotoxicity |
| Onset of Effect | 24-72 hours | 3-7 days (glutathione replenishment) |
| Side Effects | Minimal; rare GI upset | Nausea, GI upset at high doses |
When to Use Which — The Decision Protocol
Your blood work tells you which supplement to choose. Look at three markers: GGT, ALT, and AST. Bilirubin adds additional context.
If GGT is elevated (above 40 U/L) or bilirubin is elevated, the pattern is cholestatic. Use TUDCA 500-1,000 mg/day. GGT elevation means bile duct stress, and TUDCA is the only supplement that directly targets this mechanism. NAC alone will not resolve cholestatic GGT elevation.
If ALT and AST are elevated but GGT and bilirubin are normal, the pattern is hepatocellular injury from oxidative stress. Use NAC 600-1,200 mg/day. This is the most common pattern from oral AAS, and NAC is well-supported for this indication.
If both GGT and ALT/AST are elevated — a mixed pattern suggesting both cholestatic and oxidative stress — combine TUDCA and NAC. There are no known drug interactions between the two, and their mechanisms are complementary. A typical combined protocol: TUDCA 500-1,000 mg with breakfast, NAC 600-1,200 mg on an empty stomach between meals.
Quick Decision Protocol
Other Liver Support Options
Milk thistle (silymarin) is the most commonly used liver supplement among AAS users, but the evidence is weaker than for TUDCA or NAC. A 2020 Cochrane review found that silymarin produced inconsistent results for liver enzyme reduction across clinical trials, and the studies that showed positive effects used pharmaceutical-grade silymarin at doses (420-840 mg/day) far higher than most over-the-counter supplements provide. Milk thistle can be used as a tertiary support, but it should not be the foundation of your liver protection strategy.
SAM-e (S-adenosylmethionine) is sometimes recommended for liver support, but the evidence in AAS users specifically is mixed. SAM-e is better supported for cholestasis in pregnancy and certain chronic liver conditions than for AAS-induced hepatic stress. If cost is not a concern, it can be added as a tertiary option, but TUDCA and NAC should be the foundation.